Cargando…
Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease
BACKGROUND: Unlike multiple sclerosis and neuromyelitis optica, the burden of fatigue in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is unclear. OBJECTIVE: To compare fatigue levels between people with MOGAD and household controls (HC) and explore factors associated with...
Autores principales: | Ladakis, Dimitrios C, Gould, Jennifer, Khazen, Jenny M, Lefelar, Julia M, Tarpey, Scott, Bies, Charles J, Salky, Rebecca, Fitzgerald, Kathryn C, Bhargava, Pavan, Nourbakhsh, Bardia, Sotirchos, Elias S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669694/ https://www.ncbi.nlm.nih.gov/pubmed/36407471 http://dx.doi.org/10.1177/20552173221131235 |
Ejemplares similares
-
Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
por: Santoro, Jonathan D., et al.
Publicado: (2023) -
Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
por: Santoro, Jonathan D., et al.
Publicado: (2023) -
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
por: Lotan, Itay, et al.
Publicado: (2023) -
Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023) -
T-cell responses to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis
por: Ewing, C., et al.
Publicado: (1998)